Excited to share our newly published study in the prestigious British Journal of Cancer @BrJCancer. #Oncology #Sarcoma #BrainMetastases #Neurooncology

💡Explore the latest breakthroughs in #CNS #radiationoncology as presented at #ESTRO25 — from simulation-free planning and LET-guided dose sculpting to #adaptiveRT and next-gen imaging biomarkers. 👉 #CNSOncology #Radonc #NeuroOncology #BrainMetastases

What is the utility of arterial spin labeling perfusion MRI (#ASLMRI) for accurately differentiating between #RadiationNecrosis and tumor in #BrainMetastases treated with #StereotacticRadiosurgery? . Read the article in our latest issue:

Visit tomorrow's poster session on Central Nervous System Tumors at #ASCO25 and check out new research from Dr. Jose Pablo Leone and colleagues on risk factors for #BrainMetastases in patients with #MetastaticBreastCancer. #MBC #BreastCancer #BrainMets

Long-term outcomes from NRG CC001!!.➡️WBRT + meantime +\- HA.➡️Median Fu 12 mo.🗣Continued .👉Preservation of cognitive function 👉Prevention of neurologic symptoms.👉No difference in survival or toxicity.#radonc #brainmetastases

Tomorrow at #ESMO24 Dr. Nancy Lin (@nlinmd) will be presenting primary results from DESTINY-Breast12: Trastuzumab deruxtecan in patients with HER2+; advanced/ #MetastaticBreastCancer with or without #BrainMetastases. #TDXd #mBC .🗓️ Friday, Sept 13th.⏰ 16:00 - 16:10 CEST (10:00

Dr. Thorsten Füreder, #TUXEDO3 investigator, shares insights on patritumab deruxtecan (HER3-DXd) in advanced NSCLC with active brain metastases. Results presented at #ASCO25. 📽️ Interview + article 👉. #ClinicalTrials #NSCLC #BrainMetastases #Oncology.

Dr. Jose Pablo Leone at the #ASCO25 #CNS Poster Session showcasing research on risk factors for #BrainMetastases in patients with #MetastaticBreastCancer. The analysis of US electronic health records found that clinical characteristics, including metastatic distribution and

📅 March Event: Brain Metastases! 🧠.Healthcare professionals, join us to enhance your skills in managing brain mets. From diagnosis to beyond treatment, let's support our patients together!.🔗 More info and sign up: #BrainMetastases #Oncology

Check out this @NatureMedicine review which defines the RANO criteria for response assessment of #BrainMetastases based on amino acid PET imaging. 👉@ProfNAlbert @galldiks @MJ_Mair @gminniti2012.@jana_ivanidze @nlinmd

At #ASCO24, Dr. Matthias Preusser, Principal Investigator of the #TUXEDO3trial and Head of the Division of Oncology at @MedUni_Wien, discusses the MEDSIR collaborative model and how Investigator-Initiated Trials offer hope for patients. #IITs #BrainMetastases #MedicalResearch

Dr. Nancy Lin (@nlinmd) shared exciting new DESTINY-Breast12 primary results at #ESMO24 on the use of #TrastuzumabDeruxtecan in patients with HER2+ #MetastaticBreastCancer with or without #BrainMetastases. #TDXd #mBC #BreastCancer

CLINICAL ABSTRACTS | Intracranial #RSS2023 . Never have I ever, had multiple presentations in one session. Do I just stay on the podium or do I get down and go up again? #brainmetastases #srs #saynotowholebrainRT #NeverHaveIEver

Hope you’ll have a chance to come by our poster for #TrialsInProgress at #ASCO23. Our pilot IIT for #lifileucel #TIL cell therapy in patients with #melanoma #brainmetastases is accruing at @MSKCancerCenter and soon @StanfordCancer! Great collaboration with @alexshoushtari!

🆕 in @JAMAOnc :💣 The U-BOMB Phase 2 Non-RCT:. Utidelone ➕ Bevacizumab for ERBB2-negative #MetastaticBreastCancer 🎀with active #BrainMetastases 🧠. 👩 N=47.✅ CNS ORR: 42.6%.📊 Median PFS: 7.7 months.⚠️ Manageable toxicity. 🔗 @OncoAlert

Welcome to the lab, Charlotte! Charlotte will help us to develop new computational tools to understand and treat #brainmetastases. #GephartLab #cancerresearch

Target volumes while considering Pre-op vs Post-op SRS for #brainmetastases #NRGBN012 @joshuapalmermd @EvanThomas84 @stuxrt @Rrkotecha @ASTRO_org

Join @DanaFarber 's Nancy Lin, MD (@nlinmd) and Ayal Aizer, MD, MHS (@AyalAizer), as they share and discuss research updates and advances in the treatment of #BrainMetastases. 📅 Friday, Feb. 28 at 1 - 2 p.m. ET, followed by a Q&A session. Don’t miss out! #BreastCancerResearch

Learn about #BrainMetastases prevalence by therapy line and incidence of #BreastCancerBrainMetastases in this just published cohort study in @JNCI_Now. 👉@drsarahsam @DrTimothyErick @FilippoMontemu1 @stolaney1 #JosePabloLeone @nlinmd